Biomolecules in tissue engineered medical products (TEMPs): A case study of recombinant human bone morphogenetic protein-2 (rhBMP-2)

ASTM Special Technical Publication

Volumn , Issue 1452, 2004, Pages 150-171

  Porter, Thomas J ^a   Rathore, Suman ^a   Rouse, Jason ^a   Denton, Mary ^a  

^a PFIZER INC   (United States)

Author keywords

Absorbable Collagen Sponge; Biologic; Fracture repair; Osteoinductive; Recombinant Bone Morphogenetic Protein; rhBMP 2; rhBMP 2 ACS

Indexed keywords

DEGRADATION; FRACTURE; OXIDATION; PH; PROTEINS; PURIFICATION; SOLUBILITY;

BIOMOLECULES; FRACTURE REPAIR; SPECIES;

TISSUE;

EID: 3242690683     PISSN: 00660558     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1520/stp11643s     Document Type: Conference Paper

References (17)

1. Urist M.R., "Bone Formation by Autoinduction," Science, Vol. 150, 1965, pp. 893-899.
2. Wozney J.M., Rosen V., Celeste A.J., Mitsock L.M., Whitters M.J., Kriz R.W., Hewick R.M., Wang E.A., "Novel Regulators of Bone Formation: Molecular Clones and Activities," Science, Vol. 242, 1988, pp. 1528-1534.
3. Israel D.I., Nove J., Kerns K.M., Moutsatsos I.K., Kaufman R.J., "Expression and Characterization of Bone Morphogenetic Protein-2 in Chinese Hamster Ovary Cells," Growth Factors; Vol. 7, 1992, pp. 139-150.
4. Fukawa H., "Changes of Glutamine-Peptides on Heating in Aqueous Media," Journal of the Chemical Society of Japan, Vol. 88, 1967, pp. 459-463.
5. Kleeman T.J., Ahn U.M., Talbot-Kleeman A., "Laparoscopic Anterior Lumbar Interbody Fusion with rhBMP-2: A Prospective Study of Clinical And Radiographic Outcomes," Spine, Vol. 26, 2001, pp. 2751-2756.
6. Riedel G.E., Valentin-Opran A., "Clinical Evaluation of rhBMP-2/ACS in Orthopedic Trauma: a Progress Report," Orthopedics, Vol. 22, 1999, pp. 663-665.
7. Wang E.A., Rosen V., D'Alessandro J.S., Bauday, M., Cordes, P., Harada, T., Israel, D.I., Hewick, R.M., Kerns, K.M., LaPan, P., Luxenburg, D.P., McQuaid, D., Moutsatsos, I.K., Nove, J., and Wozney, J.M., "Recombinant Human Bone Morphogenetic Protein Induces Bone Formation," Proceedings of the National Academy of Science USA, Vol. 87, 1990, pp. 2220-2224.
8. Seeherman H., Wozney J., Li R., "Bone Morphogenetic Protein Delivery Systems," Spine, Vol. 27 (16 Suppl 1), 2002, pp. S16-S23.
9. Uludag H., Gao, T., Porter, T.J., Friess, W., Wozney, J.M., "Delivery Systems for BMPs: Factors Contributing to Protein Retention at an Application Site," Journal of Bone and Joint Surgery, Vol. 83-A, Part 2, Supplement 1, 2001, pp. S128-S135.
10. Gao T.J., Kousinioris N.A., Wozney J.M., Winn S., Uludag H., "Synthetic Thermoreversible Polymers are Compatible with Osteoinductive Activity of Recombinant Human Bone Morphogenetic Protein 2," Tissue Engineering., Vol. 8, 2002, pp. 429-440.
11. Helm G., Anderson D.G., Andersson G.B., Boden S.D., Damien C., Ebara S., Lane J.M., McKay B., Sandhu H.S., Seeherman H., Wozney J., "Summary Statement: Bone Morphogenetic Proteins: Basic Science," Spine Vol. 27 (16 Suppl 1), 2002, p. S9.
12. Uludag, H., D'Augusta, D., Golden, J., Li, J., Timony, G., Riedel, R., Wozney, J., "Implantation of Recombinant Human Bone Morphogenetic Proteins with Biomaterial Carriers: a Correlation Between Protein Pharmacokinetics and Osteoinduction in The Rat Ectopic Model," Journal of Biomedical Materials Research, Vol. 50, 2000, pp. 227-238.
13. Thies R.S., Bauduy M., Ashton B., Kurtzberg L., Wozney J.M., Rosen V., "Recombinant Human Bone Morphogenetic Protein-2 Induces Osteoblastic Differentiation in W-20-17 Stromal Cells," Endocrinology, Vol. 180, 1992, pp. 1318-1324.
14. Urist, M.R. in "Bone Morphogenetic Proteins: Biology, Biochemistry and Reconstructive Surgery," ed. Lindholm, T.S., R.G. Landes Co. and Academic Press, Inc., 1996, pp. 7-27.
15. Kress B.C., "Bone Alkaline Phosphatase: Methods of Quantitation and Clinical Utility," Journal of Clinical Ligand Assay, Vol. 21, 1998, pp. 139-148.
16. Porter, T.J., "Chemical Oxidation of Recombinant Human Factor IX and Recombinant Human Bone Morphogenetic Protein-2: Characterization of the Oxidized Proteins," IBC conference on The Impact of Post-Translational Modifications on Protein Therapeutics, May 8-10, 2002, San Diego CA
17. Kirsch T., Sebald W., Dreyer M.K., "Crystal Structure Of The BMP-2 BRIA Ectodomain Complex," Nature Structural Biology, Vol. 7, 2000, pp. 492-496.